Though ELISA tests (enzyme-linked immunosorbent assays) are the gold standard for diagnosing a whole slew of infectious diseases, the technology has remained stuck within hospital labs. What if you ...

Scientists say they have developed a new computational method to reduce variability in common research biomarker tests. They see their techniques as a promising step in improving the ability of ...

The hepatitis testing market presents significant opportunities driven by rising hepatitis infections, increasing demand for early diagnosis, and advancements in rapid point-of-care testing. Key ...

An ELISA test should always be performed in replicates (duplicates or triplicates) so as to achieve enough number of samples to calculate the standard deviation and ...

The launch follows increasing demand from the scientific community to study penKid - a biomarker reflecting the current state of kidney function in critical care environments. While SphingoTec's ...

LUXEMBOURG-- (BUSINESS WIRE)--In a continued effort to help fight the COVID-19 crisis, Eurofins Technologies announces the CE-IVD marking of a first range of testing kits for serology-based antibody ...

COVID-19 has thrown ELISA testing into the spotlight and driven advances in technology allowing the process to become quicker and more accurate. While there are limits to ELISA antibody tests’ ...